Drugs / Latanoprost/Timolol
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT01779284 Comparator | Jan → Dec 2012 | glaucoma | Aristotle University Of Thessaloniki | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Latanoprost/Timolol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01779284 ↗ |
| Route | Other | “All patients will be crossed over to therapy for 3 months with latanoprost/timolol fixed combination drops administered once in the evening.” NCT01779284 ↗ |